Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Rimonabant (SR141716): Reliable CB1 Antagonist for Lab Assay
2026-06-15
This authoritative guide addresses lab challenges in cell viability and appetite regulation research, showing how Rimonabant (SR141716) (SKU B1429) from APExBIO offers reproducible, data-driven solutions. Scenario-based insights clarify protocol optimization, data interpretation, and product selection for endocannabinoid system studies.
-
Non-Canonical Dlat-Trpv3 Pathway Drives Adipose Thermogenesi
2026-06-15
This study reveals that hyperforin promotes adipose thermogenesis via a novel Dlat-Trpv3-Ca2+-AMPK signaling axis, providing an alternative to β3-adrenergic receptor-targeted anti-obesity strategies. The findings highlight a mechanism that avoids cardiac side effects and is supported by robust in vivo and in vitro experimentation.
-
HBsAg Exploits TBK1 to Suppress Interferon and Induce Autoph
2026-06-14
This study reveals a novel mechanism by which hepatitis B surface antigen (HBsAg) interacts with TANK-binding kinase 1 (TBK1), suppressing type I interferon production and inducing early, incomplete autophagy. These findings clarify how HBV evades innate immunity, with implications for therapeutic targeting in chronic hepatitis B.
-
Diethylmaleate in Redox Regulation: Protocols and Advanced U
2026-06-13
Diethylmaleate, a gold-standard oxidative stress research chemical, enables precise glutathione depletion and GST inhibition for dissecting redox pathways and resistance mechanisms. This article translates cutting-edge findings into actionable workflows, troubleshooting tips, and comparative insights—empowering toxicology and redox regulation studies with greater reproducibility and mechanistic depth.
-
Diethylmaleate: Strategic Redox Modulation for Translational
2026-06-12
This thought-leadership article explores the mechanistic and strategic value of Diethylmaleate as a tool for translational researchers. By integrating recent insights into glutathione S-transferase (GST)–mediated resistance mechanisms and advanced redox modeling, it highlights how targeted glutathione depletion can inform experimental design and resistance management. The discussion connects foundational evidence, such as the role of GST in insecticide resistance, to broader opportunities in toxicology and reproductive system studies, while offering practical guidance and a forward-looking perspective.
-
GS-441524 Prodrug: Workflows, Troubleshooting, and Antiviral
2026-06-12
Unlock the full potential of GS-441524 in antiviral research with practical workflows and troubleshooting insights. This guide draws on the latest LC–MS/MS conversion mapping and APExBIO’s research-grade quality to streamline your anti-SARS-CoV-2 nucleoside analog experiments.
-
Crystal Violet Staining: Precision Tools for Translational R
2026-06-11
Explore how mechanistic insights from biofilm and cell-based assays drive strategic advances in translational research. This article connects the molecular rationale for nuclear staining dyes, such as APExBIO's Crystal Violet Staining Solution, to experimental best practices and future innovation in therapeutic development. Drawing on recent evidence, including LL-37 antibiofilm studies, and bridging to practical guidance, it delivers actionable perspectives for researchers advancing from bench to bedside.
-
O-GlcNAcylation Controls HUWE1-TfR1 Axis in Preeclampsia Fer
2026-06-11
This study reveals how O-GlcNAc modification of the E3 ligase HUWE1 regulates transferrin receptor 1 (TfR1) degradation and ferroptosis in placental trophoblasts, a mechanism central to preeclampsia pathology. The findings highlight the therapeutic potential of targeting the O-GlcNAc–HUWE1–TfR1 axis to mitigate trophoblast stress and improve pregnancy outcomes.
-
Vernakalant Hydrochloride: Rapid AF Conversion and Ion Chann
2026-06-10
Vernakalant Hydrochloride (RSD1235) delivers rapid, atrial-selective conversion of atrial fibrillation by uniquely targeting multiple ion channels with minimal ventricular effects. This guide details practical experimental workflows, troubleshooting insights, and key innovations from landmark studies, empowering researchers and clinicians to harness its full translational potential.
-
ISRIB (trans-isomer): Evidence-Based PERK Inhibitor for ER S
2026-06-10
ISRIB (trans-isomer) is a potent PERK inhibitor that reverses eIF2α phosphorylation to restore translation during ER stress. Its robust efficacy in neuroinflammation and memory models is supported by recent evidence. APExBIO supplies this compound for advanced ER stress and cognitive research.
-
HDAC Inhibition and Drug Synergy in Pancreatic Cancer Models
2026-06-09
This study introduces a rapid in vivo screening platform using Rgs16::GFP expression to identify effective chemotherapeutic combinations for pancreatic ductal adenocarcinoma (PDA). The research highlights how the HDAC inhibitor Trichostatin A (TSA) enhances cytotoxicity of standard agents, underscoring the translational potential of epigenetic modulation in PDA therapy.
-
5-HT3 Antagonists Inhibit Renal OCT2 and MATE1: Mechanistic
2026-06-09
This study systematically investigates how 5-HT3 receptor antagonists, including tropisetron, inhibit renal organic cation transporters OCT2 and MATE1 in vitro. The findings reveal drug-specific differences in transporter inhibition, highlighting potential implications for drug-drug interactions and the pharmacokinetics of cationic therapeutics.
-
Bromodomain Inhibitor, (+)-JQ1: Reliable BET Assay Solutions
2026-06-08
This article guides biomedical researchers and laboratory professionals through practical, scenario-driven challenges in BET bromodomain inhibition workflows. Drawing from recent literature and real-world protocol needs, we demonstrate how Bromodomain Inhibitor, (+)-JQ1 (SKU A1910) delivers reproducible, data-validated performance for apoptosis assays, inflammation modulation, and BRDT-targeted studies.
-
Electrostatic Insights: Cy5 Maleimide (Non-sulfonated) for P
2026-06-08
Explore how Cy5 maleimide (non-sulfonated) enables advanced, charge-dependent protein labeling and partitioning. This article reveals new electrostatic considerations for probe design that go beyond standard thiol-reactive dye applications.
-
Scenario-Driven Solutions with Pazopanib (GW-786034) in Canc
2026-06-07
This article addresses real lab challenges in cell viability and tumor biology assays, highlighting how Pazopanib (GW-786034) (SKU A3022) from APExBIO delivers reliable, reproducible results. Readers will find scenario-based guidance, quantitative context, and practical protocol parameters to optimize workflows using this multi-targeted RTK inhibitor.